SQZ Biotechnologies Statistics
SQZ Biotechnologies (SQZB) Stock Statistics & Valuation Metrics
Total Valuation
SQZ Biotechnologies has a market cap or net worth of $707.79K. The enterprise value is $13.65M.
- Market Cap
- $707.79K
- Enterprise Value
- $13.65M
Share Statistics
SQZ Biotechnologies has 29,491,125 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 29,491,125
- Owned by Insiders
- ―
- Owned by Institutions
- 5.49%
Financial Efficiency
SQZ Biotechnologies’s return on equity (ROE) is -1.39 and return on invested capital (ROIC) is -81.66%.
- Return on Equity (ROE)
- -1.39
- Return on Assets (ROA)
- -0.74
- Return on Invested Capital (ROIC)
- -81.66%
- Return on Capital Employed (ROCE)
- -0.95
- Revenue Per Employee
- 396.77K
- Profits Per Employee
- -1.50M
- Employee Count
- 53
- Asset Turnover
- 0.20
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of SQZ Biotechnologies is -0.01. SQZ Biotechnologies’s PEG ratio is -0.00.
- PE Ratio
- -0.01
- PS Ratio
- 0.03
- PB Ratio
- 0.01
- Price to FCF
- -0.01
- Price to Operating Cash Flow
- -0.01
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, SQZ Biotechnologies had revenue of 21.03M and earned -79.46M in profits. Earnings per share was -2.76.
- Revenue
- 21.03M
- Gross Profit
- 9.79M
- Operating Income
- -80.68M
- Pretax Income
- -79.46M
- Net Income
- -79.46M
- EBITDA
- -64.14M
- Earnings Per Share (EPS)
- -2.76
Cash Flow
In the last 12 months, operating cash flow was -74.33M and capital expenditures -213,000, giving a free cash flow of -74.55M billion.
- Operating Cash Flow
- -74.33M
- Free Cash Flow
- -74.55M
- Free Cash Flow per Share
- -2.92
Dividends & Yields
SQZ Biotechnologies pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -11878.01%
- Earnings Yield
- -11491.38%
Stock Price Statistics
- Beta
- 0.42
- 52-Week Price Change
- 0.00%
- 50-Day Moving Average
- 0.02
- 200-Day Moving Average
- 0.02
- Relative Strength Index (RSI)
- 48.15
- Average Volume (3m)
- 41.62K
Important Dates
SQZ Biotechnologies upcoming earnings date is ―, TBA (Not Confirmed).
- Last Earnings Date
- Nov 06, 2024
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Financial Position
SQZ Biotechnologies as a current ratio of 3.12, with Debt / Equity ratio of 60.14%
- Current Ratio
- 3.12
- Quick Ratio
- 3.12
- Debt to Market Cap
- 0.32
- Net Debt to EBITDA
- 0.46
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, SQZ Biotechnologies has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
SQZ Biotechnologies EV to EBITDA ratio is 0.45, with an EV/FCF ratio of 0.34.
- EV to Sales
- -1.36
- EV to EBITDA
- 0.45
- EV to Free Cash Flow
- 0.34
- EV to Operating Cash Flow
- 0.34
Balance Sheet
SQZ Biotechnologies has $10.19M in cash and marketable securities with $21.47M in debt, giving a net cash position of -$11.28M billion.
- Cash & Marketable Securities
- $10.19M
- Total Debt
- $21.47M
- Net Cash
- -$11.28M
- Net Cash Per Share
- -$0.38
- Tangible Book Value Per Share
- $0.06
Margins
Gross margin is 46.57%, with operating margin of -383.68%, and net profit margin of -377.88%.
- Gross Margin
- 46.57%
- Operating Margin
- -383.68%
- Pretax Margin
- -377.88%
- Net Profit Margin
- -377.88%
- EBITDA Margin
- -305.01%
- EBIT Margin
- -360.57%

